Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flow cytometry: its applications in hematology

A Orfao1, A Ruiz-Arguelles, F Lacombe

  • 1Laboratory of Hematology, University Hospital of Salamanca, Spain.

Haematologica
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison between five pattern-based approaches for automated diagnostic classification of mature/peripheral B-cell neoplasms based on standardized EuroFlow flow cytometry immunophenotypic data.

Computers in biology and medicine·2025
Same author

A decision-tree approach for the differential diagnosis of chronic lymphoid leukemias and peripheral B-cell lymphomas.

Computer methods and programs in biomedicine·2019
Same author

Self-reported changes in the expanded disability status scale score in patients with multiple sclerosis after autologous stem cell transplants: real-world data from a single center.

Clinical and experimental immunology·2019
Same author

From big flow cytometry datasets to smart diagnostic strategies: The EuroFlow approach.

Journal of immunological methods·2019
Same author

Impact of blood storage and sample handling on quality of high dimensional flow cytometric data in multicenter clinical research.

Journal of immunological methods·2019
Same author

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).

Blood cancer journal·2018

Flow cytometry is an increasingly vital tool in clinical hematology, offering valuable insights for diagnosing and managing various blood disorders. This technology aids in immunophenotyping, assessing cell proliferation, and detecting drug resistance in leukemias and lymphomas.

Area of Science:

  • Clinical Hematology
  • Immunology
  • Cell Biology

Background:

  • Flow cytometry (FCM) has evolved from a specialized technique to a mature discipline in clinical hematology.
  • Its methodology is well-established, instrumentation is widely available, and its clinical utility is increasingly recognized.
  • A significant increase in scientific literature highlights the growing interest in FCM for both research and patient care.

Purpose of the Study:

  • To highlight the significant role and applications of flow cytometry in modern clinical hematology.
  • To discuss key areas within hematology where FCM provides substantial benefits.
  • To underscore the importance of FCM as a diagnostic and research tool.

Main Methods:

  • The paper reviews established and emerging applications of flow cytometry in hematology.

Related Experiment Videos

  • Focus is placed on four critical areas: immunophenotyping, proliferation and DNA ploidy analysis, drug resistance detection, and platelet studies.
  • Methodologies are discussed in the context of their clinical relevance and impact.

    • Main Results:

    • Flow cytometry is instrumental in the immunophenotypic classification of leukemias and lymphomas.
    • It enables accurate measurement of proliferative activity and DNA ploidy in hematological malignancies.
    • FCM is effective in detecting drug-resistant leukemic cells and is valuable in the study of platelet function and disorders.

    Conclusions:

    • Flow cytometry is an indispensable technology in the contemporary clinical hematology laboratory.
    • Its applications significantly enhance the diagnosis, prognosis, and management of hematological malignancies and other blood disorders.
    • Continued research and development in FCM promise further advancements in patient care and medical research.